We are live on ! Find out more
EVGN icon

Evogene
EVGN

38 hedge funds and large institutions have $2.8M invested in Evogene in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.87% less ownership

Funds ownership: 1.46% → 0.59% (-0.87%)

10% less funds holding

Funds holding: 42 → 38 (-4)

23% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 13

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

72% less capital invested

Capital invested by funds: $10M → $2.8M (-$7.23M)

87% less call options, than puts

Call options by funds: $25K | Put options by funds: $187K

Holders
38
Holders Change
-4
Holders Change %
-9.52%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
13
Closed
7
Calls
$25K
Puts
$187K
Net Calls
-$162K
Net Calls Change
+$185K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$211K
2
Bank of America
Bank of America
North Carolina
+$91.5K
3
Morgan Stanley
Morgan Stanley
New York
+$50.4K
4
VF
Virtu Financial
New York
+$49.3K
5
VIA
Vident Investment Advisory
Georgia
+$46K

Top Sellers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
-$6.02M
2
Citadel Advisors
Citadel Advisors
Florida
-$115K
3
CS
Credit Suisse
Switzerland
-$94K
4
Millennium Management
Millennium Management
New York
-$67.6K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$52.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
26
Walleye Capital
New York
$15K -$18.5K -1,370 -55%
JP Morgan Chase
27
JP Morgan Chase
New York
$13K -$10.6K -787 -44%
SFG
28
SNS Financial Group
Minnesota
$13K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$10K – – –
Simplex Trading
30
Simplex Trading
Illinois
$7K -$10.3K -762 -56%
SPIA
31
Steward Partners Investment Advisory
New York
$7K – – –
TRCT
32
Tower Research Capital (TRC)
New York
$6K -$4.95K -367 -45%
SWM
33
Spire Wealth Management
Virginia
$4K – – –
CG
34
Cutler Group
California
$3K -$1.82K -135 -34%
HR
35
Howe & Rusling
New York
$1K – – –
SCM
36
Silverarc Capital Management
Massachusetts
$384 +$3.63K +269 +0.9%
AIM
37
ARK Investment Management
Florida
– -$6.02M -361,184 Closed
CS
38
Credit Suisse
Switzerland
– -$94K -5,728 Closed
Goldman Sachs
39
Goldman Sachs
New York
– -$48K -2,911 Closed
Walleye Trading
40
Walleye Trading
New York
– -$23K -1,384 Closed
HF
41
HRT Financial
New York
– -$22K -1,345 Closed
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
– -$971 -72 -81%
EWM
43
Edge Wealth Management
New York
– -$1K -5 Closed
Wells Fargo
44
Wells Fargo
California
– +$216 +16 New
1
2

EVGN Hedge Fund Activity: Q1 2022 in Review

38 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q1 2022, worth a combined $2.8M — down 72% from $10M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of EVGN and 3 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 10 added.

The largest buyer was Renaissance Technologies, adding an estimated $211K. The largest seller was ARK Investment Management, exiting entirely with an estimated $6.02M sold.

  • 38 institutional investors held Evogene (EVGN) as of Q1 2022, down from 42 in Q4 2021.
  • Funds reported $2.8M of Evogene stock for Q1 2022, down 72% quarter-over-quarter.
  • 3 funds opened new Evogene positions in Q1 2022 and 7 closed out, a net change of -4 holders.
  • The largest Evogene buyer in Q1 2022 was Renaissance Technologies, an estimated $211K added.
  • The largest Evogene seller in Q1 2022 was ARK Investment Management, an estimated $6.02M sold.

Based on aggregated 13F filings for Q1 2022.